483
Paul W. Wallace, MDFDA 483 - Paul W. Wallace, MD - March 17, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Paul W. Wallace, MD in Los Angeles, CA, revealed significant deviations from investigational plans. The firm failed to complete numerous required procedures and assessments for multiple subjects across two protocols. Additionally, a large number of enrolled subjects missed all study visits due to personnel changes, indicating a severe lack of adherence to clinical trial protocols.
Open in Dashboard
ID · 6412ed93-d955-4c0b-a44c-e8cf3b5a5cfa